Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation
Abstract The stem cell ability to self-renew and lead regeneration relies on the balance of complex signals in their microenvironment. The identification of modulators of hepatic progenitor cell (HPC) activation is determinant for liver regeneration and may improve cell transplantation for end-stage...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d61f8bccbb224beb9600090ce80a0056 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d61f8bccbb224beb9600090ce80a0056 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d61f8bccbb224beb9600090ce80a00562021-12-02T15:00:39ZInhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation10.1038/s41536-021-00137-z2057-3995https://doaj.org/article/d61f8bccbb224beb9600090ce80a00562021-05-01T00:00:00Zhttps://doi.org/10.1038/s41536-021-00137-zhttps://doaj.org/toc/2057-3995Abstract The stem cell ability to self-renew and lead regeneration relies on the balance of complex signals in their microenvironment. The identification of modulators of hepatic progenitor cell (HPC) activation is determinant for liver regeneration and may improve cell transplantation for end-stage liver disease. This investigation used different models to point out the Nuclear factor (erythroid-derived 2)-like 2 (NRF2) as a key regulator of the HPC fate. We initially proved that in vivo models of biliary epithelial cells (BECs)/HPC activation show hepatic oxidative stress, which activates primary BECs/HPCs in vitro. NRF2 downregulation and silencing were associated with morphological, phenotypic, and functional modifications distinctive of differentiated cells. Furthermore, NRF2 activation in the biliary tract repressed the ductular reaction in injured liver. To definitely assess the importance of NRF2 in HPC biology, we applied a xenograft model by inhibiting NRF2 in the human derived HepaRG cell line and transplanting into SCID/beige mice administered with anti-Fas antibody to induce hepatocellular apoptosis; this resulted in effective human hepatocyte repopulation with reduced liver injury. To conclude, NRF2 inhibition leads to the activation and differentiation of liver progenitors. This redox-dependent transcription factor represents a potential target to regulate the commitment of undifferentiated hepatic progenitors into specific lineages.Francesco BellantiGiorgia di BelloGiuseppina IannelliGiuseppe PannoneMaria Carmela PedicilloLuke BoulterWei-Yu LuRosanna TamborraRosanna VillaniGianluigi VendemialeStuart J. ForbesGaetano ServiddioNature PortfolioarticleMedicineRENnpj Regenerative Medicine, Vol 6, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Francesco Bellanti Giorgia di Bello Giuseppina Iannelli Giuseppe Pannone Maria Carmela Pedicillo Luke Boulter Wei-Yu Lu Rosanna Tamborra Rosanna Villani Gianluigi Vendemiale Stuart J. Forbes Gaetano Serviddio Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
description |
Abstract The stem cell ability to self-renew and lead regeneration relies on the balance of complex signals in their microenvironment. The identification of modulators of hepatic progenitor cell (HPC) activation is determinant for liver regeneration and may improve cell transplantation for end-stage liver disease. This investigation used different models to point out the Nuclear factor (erythroid-derived 2)-like 2 (NRF2) as a key regulator of the HPC fate. We initially proved that in vivo models of biliary epithelial cells (BECs)/HPC activation show hepatic oxidative stress, which activates primary BECs/HPCs in vitro. NRF2 downregulation and silencing were associated with morphological, phenotypic, and functional modifications distinctive of differentiated cells. Furthermore, NRF2 activation in the biliary tract repressed the ductular reaction in injured liver. To definitely assess the importance of NRF2 in HPC biology, we applied a xenograft model by inhibiting NRF2 in the human derived HepaRG cell line and transplanting into SCID/beige mice administered with anti-Fas antibody to induce hepatocellular apoptosis; this resulted in effective human hepatocyte repopulation with reduced liver injury. To conclude, NRF2 inhibition leads to the activation and differentiation of liver progenitors. This redox-dependent transcription factor represents a potential target to regulate the commitment of undifferentiated hepatic progenitors into specific lineages. |
format |
article |
author |
Francesco Bellanti Giorgia di Bello Giuseppina Iannelli Giuseppe Pannone Maria Carmela Pedicillo Luke Boulter Wei-Yu Lu Rosanna Tamborra Rosanna Villani Gianluigi Vendemiale Stuart J. Forbes Gaetano Serviddio |
author_facet |
Francesco Bellanti Giorgia di Bello Giuseppina Iannelli Giuseppe Pannone Maria Carmela Pedicillo Luke Boulter Wei-Yu Lu Rosanna Tamborra Rosanna Villani Gianluigi Vendemiale Stuart J. Forbes Gaetano Serviddio |
author_sort |
Francesco Bellanti |
title |
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
title_short |
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
title_full |
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
title_fullStr |
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
title_full_unstemmed |
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
title_sort |
inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/d61f8bccbb224beb9600090ce80a0056 |
work_keys_str_mv |
AT francescobellanti inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT giorgiadibello inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT giuseppinaiannelli inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT giuseppepannone inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT mariacarmelapedicillo inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT lukeboulter inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT weiyulu inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT rosannatamborra inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT rosannavillani inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT gianluigivendemiale inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT stuartjforbes inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation AT gaetanoserviddio inhibitionofnuclearfactorerythroidderived2like2promoteshepaticprogenitorcellactivationanddifferentiation |
_version_ |
1718389166835761152 |